References
- Van Cutsem J, Van Gerven F, Fransen J, Schrooten P, Janssen P AJ. The in vitro antifungal activity of keto-conazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermatol 1990; 22: 993–8
- Skinner R B., Noah P W., Taylor R M., Zanolli M D., West S, Guin J D. Rosenberg EW, Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852–6
- Kousidou T, Panagiotidou D, Boutli F, Mourellou O, Loannidis D, Fotidou D, Minas A, Anthopoulou H, Michailidis D. A double-blind comparison of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of seborrheic dermatitis. Curr Ther Res 1992; 51(5)723–9
- Katsambas A, Antoniou C H., Frangouli E, Avgerinou G, Michailidis D, Stratigos J. A double-blind trial of treatment of seborrheic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol 1989; 121: 353–7
- Faergeman J. Seborrheic dermatitis and Pityrosporum orbiculare: treatment of seborrheic dermatitis of the scalp with miconazole-hydrocortisone (Kaktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695–700
- Belew P W., Rosenberg E W., Jennings B R. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale). Mycopathologia 1980; 70: 187–91
- Sohnle P G., Collin-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983; 80: 93–7
- Terui T, Rokugo M, Kato T, Tagami H. Analysis of the proinflammatory property of epidermal cyst contents: chemotactic CSa anaphylatoxin generation. Arch Dermatol Res 1989; 281: 31–4
- Tagami H, Ofuji S. Characterization of leukotactic factor derived from psoriatic scale. Br J Dermatol 1977; 97: 509–18
- Tagami H, Kitano Y, Suehisa S, Oku T, Yamada M. Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells. Arch Dermatol Res 1982; 272: 201–13
- Van Cutsem J, Van Gerven F, Cauwenbergh G, Odds F, Janssen P AJ. The antiinflammatory effects of ketoconazole. J Am Acad Dermatol 1991; 25: 257–61
- Rosenberg E W., Belew P, Bale G. Effect of topical applications of heavy suspensions of killed Malassezia avails on rabbit skin. Mycopathologia 1980; 72: 147–54
- Pinkus H, Mehregan A H. Seborrheic dermatitis and psoriasis. J Invest Dermatol 1966; 46: 109–16
- Schroder J-M, Christophers E. Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986; 87: 53–8
- Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 1993; 129: 74–80
- Kikuchi T, Horii I, Sakamoto T, Nakayama Y, Tagami H. Demonstration of neutrophil chemotactic anaphylatoxins in human dandruff. Arch Dermatol Res 1989; 281: 482–6
- Rosenberg E W., Noah P W., Skinner R B., Jr. Psoriasis is a visible manifestation of the skin's defense against microorganisms. J Dermatol 1994; 26: 375–81
- Beetens J R., Loots W, Somers Y, Coene M C., De Clerck F. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem Pharmacol 1986; 35(6)883–91